Anthracyclines in Early Breast Cancer: Patient Perspectives and Expert Debate
You may have to sign in to view these fascinating video presentations. Well worth the effort,especially if you are on the fence about ACTH vs TCH.
Anthracyclines Should Remain a Mainstay of Adjuvant Chemotherapy
Mark Levine, MD, reviews clinical trial data supporting the use of anthracyclines in adjuvant breast cancer therapy.
To view this Virtual Presentation, click here.
The Use of Nonanthracycline-Based Regimens in Early Breast Cancer
Dennis J. Slamon, MD, PhD, discusses the use of nonanthracycline-based regimens to treat patients with early breast cancer.
To view this Virtual Presentation, click here.
__________________
Smile On!
Laurel
Dx'd w/multifocal DCIS/IDS 3/08
7mm invasive component
Partial mast. 5/08
Stage 1b, ER 80%, PR 90%, HER-2 6.9 on FISH
0/5 nodes
4 AC, 4 TH finished 9/08
Herceptin every 3 weeks. Finished 7/09
Tamoxifen 10/08. Switched to Femara 8/09
Bilat SPM w/reconstruction 10/08
Clinical Trial w/Clondronate 12/08
Stopped Clondronate--too hard on my gizzard!
Switched back to Tamoxifen due to tendon pain from Femara
15 Years NED
I think I just might hang around awhile....
|